{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1151.39","meta":{"source":"https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1151.39/expansion"},"url":"http://vsac.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.39","version":"CMS Pre-rulemaking eCQM 2020-05-07","name":"MixedHistologyUrothelialCellCarcinomaForUrologyCare","title":"Mixed histology urothelial cell carcinoma for Urology Care","status":"active","date":"2017-03-02","description":"(Clinical Focus: Mixed histology urothelial cell abnormalities for urology care),(Data Element Scope: This data element defines mixed urothelial cell histology, specifically micropapillary, plasmacytoid, sarcomatoid, adenocarcinoma, and squamous disease),(Inclusion Criteria: Mixed histology urothelial cell abnormalities as defined in the code list),(Exclusion Criteria: Other histological findings in the urinary bladder)","compose":{"include":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/2019-09","concept":[{"code":"128639004","display":"Transitional cell carcinoma, micropapillary (morphologic abnormality)"},{"code":"255111004","display":"Squamous cell carcinoma of bladder (disorder)"},{"code":"278046008","display":"Sarcoma of bladder (disorder)"},{"code":"35917007","display":"Adenocarcinoma, no subtype (morphologic abnormality)"},{"code":"59509005","display":"Plasmacytoid cell (morphologic abnormality)"}]}]}}